Deans' stroke musings: Coffee and cancer risk: A summary overview

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, August 9, 2017

Coffee and cancer risk: A summary overview

Good, because I'm using it for many things. You can find whatever proof you want on coffee in these 140 posts on coffee.

Coffee and cancer risk: A summary overview

European Journal of Cancer Prevention

Alicandro G, et al.

This research coveted an appraisal of the present evidence on coffee drinking and the risk of all cancers and selected cancers. Regardless of the mixed nature of the findings, the overall evidence did not display a correlation between coffee intake with cancers of the stomach, pancreas, lung, breast, ovary, and prostate. Data was limited, with the relative risk (RR) close to unity for other neoplasms, with the inclusion of those of the esophagus, small intestine, gallbladder and biliary tract, skin, kidney, brain, thyroid, along with soft tissue sarcoma and lymphohematopoietic cancer.

A pooled relative risk (RR) for an increment of 1 cup of coffee/day of 1.00 [95% confidence interval (CI): 0.99-1.01] was noted for all cancers.
Coffee drinking was linked to a reduced risk of liver cancer.
An RR was found for an increment of consumption of 1 cup/day of 0.85 (95% CI: 0.81-0.90) for liver cancer and a favorable effect on liver enzymes and cirrhosis.
Another meta-analysis illustrated an inverse association with endometrial cancer risk, with an RR of 0.92 (95% CI: 0.88-0.96) for an increment of 1 cup/day.
A potential decreased risk was detected in few studies for oral/pharyngeal cancer and for advanced prostate cancer.
Though the findings were mixed, a certain favorable effect was observed, of coffee drinking on colorectal cancer in case-control studies, in the absence of a consistent relationship in cohort studies.
For bladder cancer, the results were not consistent.
Any possible direct relation was not dose and duration related.
It could depend on a residual confounding effect of smoking.
A few studies indicated an increased risk of childhood leukemia after maternal coffee drinking during pregnancy, but data were limited and inconsistent.